二维剪切波弹性成像超声诊断MASLD肝纤维化的准确性:多层次随机效应模型Meta分析
该系统检索截至2024年2月26日的多个数据库,纳入20项观察性研究、2223例经活检证实MASLD的参与者,采用多层次随机效应模型评估二维剪切波弹性成像诊断肝纤维化的准确性。汇总ROC曲线下面积在检测≥F1、≥F2、≥F3和F4时分别为0.82、0.82、0.86和0.89,最佳截断值分别为6.432、8.174、9.418和11.548 kPa。结论认为该技术诊断性能优异,并提出了优化的截断值。
要点
- 二维剪切波弹性成像诊断MASLD肝纤维化性能优异,F4的汇总AUC为0.89。
- ≥F1、≥F2、≥F3、F4的最佳截断值分别为6.432、8.174、9.418、11.548 kPa。
- 研究提出标准化截断值的潜力,基于20项观察性研究、2223例活检证实MASLD患者。
核心结论
- 该Meta分析确定了二维剪切波弹性成像在病因特异性慢性肝病(MASLD)中用于纤维化分期的优化截断值,诊断性能优异,突显了标准化截断值的潜力。
研究设计与样本
- 多层次随机效应模型Meta分析,系统检索PubMed/MEDLINE、Embase、Scopus、Web of Science、LILACS和Cochrane Library截至2024年2月26日的全文文献。
- 纳入20项观察性研究,共2223例经活检证实MASLD的参与者,使用SuperSonic Imagine、General Electric Healthcare和Canon Medical Systems的超声设备。
- 采用线性混合效应多阈值模型计算灵敏度、特异度和汇总受试者工作特征曲线下面积。
主要发现
- 轻度纤维化(F1)、显著纤维化(F2)、进展性纤维化(F3)和肝硬化(F4)的患病率分别为30.0%、18.5%、17.9%和10.9%。
- 所有超声设备合并检测≥F1、≥F2、≥F3和F4的汇总ROC曲线下面积[95%CI]分别为0.82[0.16-0.98]、0.82[0.76-0.88]、0.86[0.77-0.93]和0.89[0.80-0.95]。
- 检测≥F1、≥F2、≥F3和F4的最佳截断值分别为6.432 kPa、8.174 kPa、9.418 kPa和11.548 kPa。
关键数值与推荐
- ≥F1的最佳截断值为6.432 kPa,汇总AUC为0.82[0.16-0.98]。
- ≥F2的最佳截断值为8.174 kPa,汇总AUC为0.82[0.76-0.88]。
- ≥F3的最佳截断值为9.418 kPa,汇总AUC为0.86[0.77-0.93]。
- F4的最佳截断值为11.548 kPa,汇总AUC为0.89[0.80-0.95]。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) imposes significant health care burdens. Early detection of advanced fibrosis and cirrhosis in MASLD is essential due to their unfavorable outcomes. This multilevel random-effects meta-analysis aimed to provide the best evidence for the diagnostic accuracy of 2-dimensional shear wave elastography in detecting liver fibrosis in biopsy-proven MASLD. APPROACH AND RESULTS: This study involves systematic search in PubMed/MEDLINE, Embase, Scopus, Web of Science, LILACS, and Cochrane Library electronic databases for full-text articles published in any language up to February 26, 2024. Included studies reported liver stiffness measurement by 2-dimensional shear wave elastography and used histological diagnosis as the gold standard. A linear mixed-effects multiple thresholds model was employed, and summary estimates for sensitivity, specificity (Sp), and summary area under the receiver operator characteristic curve were computed. Twenty observational studies (SuperSonic Imagine, General Electric Healthcare, and Canon Medical Systems) fulfilled the inclusion criteria, comprising 2223 participants with biopsy-proven MASLD. The prevalence of mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) was 30.0%, 18.5%, 17.9%, and 10.9%, respectively. The summary area under the receiver operator characteristic curve [95% CI] in detecting ≥F1, ≥F2, ≥F3, and F4 for all ultrasound machines considered together were 0.82 [0.16-0.98], 0.82 [0.76-0.88], 0.86 [0.77-0.93], and 0.89 [0.80-0.95], respectively. The optimal cutoff values were 6.432 kPa for ≥F1, 8.174 kPa for ≥F2, 9.418 kPa for ≥F3, and 11.548 kPa for F4, respectively. CONCLUSIONS: Our meta-analysis identified optimized cutoffs for fibrosis staging by 2-dimensional shear wave elastography in etiology-specific chronic liver diseases (MASLD), with excellent diagnostic performance, underscoring the potential for standardizing cutoff values.
引用
- Indre MG, Leucuta DC, Lupsor-Platon M, et al. Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multilevel random effects model meta-analysis. Hepatology. 2024. PMID: 39689354. doi:10.1097/HEP.0000000000001190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。